Simplify Propel Opportunities ETF
$17.09−0.17 (−0.96%)
- 2.82%
- $76M
- +27.5%
- 15.76%
- 0M sh
- $17.29
- low $14.90high $21.31
The ETF.net SURI Grade
F
Score 15 out of 100
- 125 of 127
Score 15 of 100 falls in the F band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.
Cost
The fund’s net expense ratio, ranked against its category.F3 out of 100Rank 123 of 127Mission
Whether the fund did what it promised, tested against its stated mandate.Risk
How the fund held up when markets fell: downside volatility, drawdowns and tail loss.F17 out of 100Rank 117 of 126Tradability
How easy the fund is to trade: daily volume, and how far its price strays from net asset value.F14 out of 100Rank 120 of 127Holdings
How concentrated the fund is, and how complete and current its disclosed holdings are.D28 out of 100Rank 113 of 124Durability
Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.B61 out of 100Rank 53 of 127
Our read on SURI
FA life-sciences venture shop in an ETF wrapper: Propel Bio's scientists hunt overlooked biotech and pharma, using preferreds, convertibles and structured notes alongside common stock. Pricing is private-fund steep.
The Fund seeks long-term capital appreciation.
Why people hold it
- Sub-advised by Propel Bio Management, a life-science investment firm whose team includes scientists and drug developers rather than generalist stock pickers.sec.govconvention.bio.org
- Wider toolkit than most healthcare funds: common and preferred stock, convertible bonds, structured notes and corporate debt, all inside a 1940 Act ETF.aaii.com
- Actively run and concentrated by design, aiming at global biotech, pharma, health tech and life-science tools names the manager judges overlooked.simplify.us
Worth knowing
- Costs 2.82% a year, built on a 2.75% base advisory fee for the first $1B of assets. Broad active core funds like DFAC or AVLC charge a small fraction of that.simplify.us
- A small fund that trades lightly, so bid-ask spreads can run wider than in mainstream healthcare ETFs.
- Non-diversified and tied to one sector, so a few clinical readouts can swing the whole portfolio.aaii.com
SURI Holdings
- Stocks
- 39
- 81%
- PAGP
Sectors
- Health Care50.9%
- Energy49.1%
Geography
- United States93.37%
- Canada3.79%
- United Kingdom1.46%
- France1.38%
SURI Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Not enough history yet.Not enough history yet.
SURI$12,750
Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | SURI |
|---|---|
| Year to date | +16.7% |
| 1 month | −6.7% |
| 3 months | −0.1% |
| 1 year | +27.5% |
| 3 years | +14.2% |
| 5 years | — |
| 10 years | — |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | SURI |
|---|---|---|
| 2026 YTD | +16.7% | |
| 2025 | +28.3% | |
| 2024 | −13.2% | |
| 2023 | −3.0% |
SURI in the news
SURI Dividends
- 15.76%
- $2.72
- $0.68 per share
- Quarterly
Distribution history
SURI Risk
- 30.5%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.37
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −47.7%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 1.18
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
SURI Cost
2.82%
SURI2.82%
- The middle half of US Active Equity funds
- Median 0.70%
118 of the 123 US Active Equity funds charge less.
Other funds in US Active Equity
- FMSTQLHA Market State Tactical Q ETFExpense ratio 1.59%1 year return +20.3%
- FWCAPWarCap Unconstrained Equity ETFExpense ratio 1.30%1 year return −1.7%
- FNLSINEOS Long/Short Equity Income ETFExpense ratio 2.89%1 year return —
- FAINTFINQ DOLLAR NEUTRAL U.S. Large Cap AI-Managed Equity ETFExpense ratio 1.25%1 year return —
- FCCFEConcourse Capital Focused Equity ETFExpense ratio 0.96%1 year return −7.1%